Latest filing published 26 Oct 2022 for Aravive, Inc., €15.2M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Fredric N. Eshelman discloses dealings in 2 companies, chiefly Aravive, Inc. and Hyperion Defi, Inc. In total, 4 filings cover trades dated from 17 November 2021 to 24 October 2022.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 26 October 2022 came the latest disclosure, a share grant for €15.2M in Aravive, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations